81287 Management gene prmtr mthyltn alys
Also known as: MGMT methylation test, glioblastoma methylation status
O-6-Methylguanine-DNA Methyltransferase (MGMT) gene promoter methylation analysis to predict glioblastoma treatment response and prognosis.
In Plain Language
Brain tumor treatment predictor; Glioblastoma prognosis test
Clinical Context
Detects MGMT promoter methylation in glioblastoma to predict chemotherapy response and survival. Methylated tumors show better temozolomide response.
RVU Information
CPT 81287 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81287?
CPT 81287 (Management gene prmtr mthyltn alys) is a Pathology & Lab code. O-6-Methylguanine-DNA Methyltransferase (MGMT) gene promoter methylation analysis to predict glioblastoma treatment response and prognosis.
Who uses CPT code 81287?
CPT 81287 is used by Pathology, Oncology, Neurosurgery. Detects MGMT promoter methylation in glioblastoma to predict chemotherapy response and survival. Methylated tumors show better temozolomide response.
When is CPT 81287 used?
Detects MGMT promoter methylation in glioblastoma to predict chemotherapy response and survival. Methylated tumors show better temozolomide response.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.